Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis

Neuro-Oncology

Volumn 7, Issue 2, 2005, Pages 134-153

  Kaur, Balveen ^a   Khwaja, Fatima W ^a   Severson, Eric A ^a   Matheny, Shannon L ^a   Brat, Daniel J ^a   Van Meir, Erwin G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ANGIOPOIETIN RECEPTOR; ENDOTHELIN 1; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TIE RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ALPHA CHAIN; ANGIOGENESIS; BETA CHAIN; CANCER GROWTH; CANCER INVASION; GENE TARGETING; GLIOBLASTOMA; HEREDITY; HUMAN; HYPOXIA; MICROENVIRONMENT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION;

ANOXIA; BRAIN NEOPLASMS; DNA-BINDING PROTEINS; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 17844371306     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851704001115     Document Type: Review

References (185)

1. Appelhoff, R.J., Tian, Y.M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., and Gleadle, J.M. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465.
2. Asano, T., Aoyagi, M., Hirakawa, K., and Ikawa, Y. (1994) Effect of endothelin-1 as growth factor on a human glioma cell line; its characteristic promotion of DNA synthesis. J. Neurooncol. 18, 1-7.
3. Bagnato, A., and Spinella, F. (2003) Emerging role of endothelin-1 in tumor angiogenesis. Trends Endocrinol. Metab. 14, 44-50.
4. Bajou, K., Maillard, C., Jost, M., Lijnen, R.H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J.M., and Noel, A. (2004) Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23, 6986-6990.
5. Barker, F.G., 2nd, Davis, R.L., Chang, S.M., and Prados, M.D. (1996) Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77, 1161-1166.
6. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO. J. 22, 4082-4090.
7. Bhattacharya, S., Michels, C.L., Leung, M.K., Arany, Z.P., Kung, A.L., and Livingston, D.M. (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes. Dev. 13, 64-75.
8. Bjorge, J.D., Chan, T.O., Antczak, M., Kung, H.J., and Fujita, D.J. (1990) Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. Proc. Natl. Acad. Sci. USA 87, 3816-3820.
9. Blancher, C., Moore, J.W., Robertson, N., and Harris, A. L. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61, 7349-7355.
10. Brat, D.J., and Van Meir, E.G. (2001) Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: A new world of angiogenesis research. Am. J. Pathol. 158, 789-796.
11. Brat, D.J., and Van Meir, E.G. (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest. 84, 397-405.
12. Brat, D.J., Castellano-Sanchez, A.A., Hunter, S.B., Pecot, M., Cohen, C. Hammond, E.H., Devi, SN., Kaur, B., and Van Meir, E.G. (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 64, 920-927.
13. Brodsky, S., Chen, J., Lee, A., Akassoglou, K., Norman, J., and Goligorsky, M.S. (2001) Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 281, H1784-H1792.
14. Broholm, H., and Laursen, H. (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS 112, 257-263.
15. Bruick, R.K., and McKnight, S.L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
16. Cai, Y.C., Barnard, G., Hiestand, L., Woda, B., Colby, J., and Banner, B. (1997) Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am. J. Surg. Pathol. 21, 1373-1377.
17. Caniggia, I., Mostachfi, H., Winter, J., Gassmann, M., Lye, S.J., Kuliszewski, M., and Post, M. (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J. Clin. Invest. 105, 577-587.
18. Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., and Poellinger, L. (2000) Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell Biol. 20, 402-415.
19. Chun, Y.S., Choi, E., Yeo, E.J., Lee, J.H., Kim, M.S., and Park, J.W. (2001) A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. J. Cell Sci. 114, 4051-4061.
20. Chun, Y.S., Choi, E., Kim, T.Y., Kim, M.S., and Park, J.W. (2002) A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene. Biochem. J. 362, 71-79.
21. Chun, Y.S., Lee, K.H., Choi, E., Bae, S.Y., Yeo, E.J., Huang, L.E., Kim, M.S., and Park, J.W. (2003) Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: Implications for tumor promotion. Cancer Res. 63, 8700-8707.
22. Clarke, K., Smith, K., Gullick, W.J., and Harris, A.L. (2001) Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway. Br. J. Cancer 84, 1322-1329.
23. Crews, S.T. (1998) Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 12, 607-620.
24. Cruz, A., Parnot, C., Ribatti, D., Corvol, P., and Gasc, J.M. (2001) Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J. Vasc. Res. 38, 536-545.
25. Detmar, M., Brown, L.F., Claffey, K.P., Yeo, K.T., Kocher, O., Jackman, R.W., Berse, B., and Dvorak, H.F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146.
26. Eggert, A., Ikegaki, N., Kwiatkowski, J., Zhao, H., Brodeur, G.M., and Himelstein, B.P. (2000) High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res. 6, 1900-1908.
27. Egidy, G., Eberl, L.P., Valdenaire, O., Irmler, M., Majdi, R., Diserens, A.C., Fontana, A., Janzer, R.C., Pinet, F., and Juillerat-Jeanneret, L. (2000) The endothelin system in human glioblastoma. Lab Invest. 80, 1681-1689.
28. El-Obeid, A., Bongcam-Rudloff, E., Sorby, M., Ostman, A., Nister, M., and Westermark, B. (1997) Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res. 57, 5598-5604.
29. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., Tian, Y.M., Masson, N., Hamilton, D.L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P.H., Pugh, C.W., Schofield, C.J., and Ratcliffe, P.J. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
30. Ferrara, N. (2004) Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 25, 581-611.
31. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604-4613.
32. Frederick, L., Wang, X.Y., Eley, G., and James, C.D. (2000) Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 60, 1383-1387.
33. Freedman, S.J., Sun, Z.Y., Kung, A.L., France, D.S., Wagner, G., and Eck, M.J. (2003) Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 10, 504-512.
34. Friedrich, E.B., Liu, E., Sinha, S., Cook, S., Milstone, D.S., MacRae, C.A., Mariotti, M., Kuhlencordt, P.J., Force, T., Rosenzweig, A., St-Arnaud, R., Dedhar, S., and Gerszten, R.E. (2004) Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol. Cell Biol. 24, 8134-8144.
35. Garayoa, M., Martinez, A., Lee, S., Pio, R., An, W.G., Neckers, L., Trepel, J., Montuenga, L.M., Ryan, H., Johnson, R., Gassmann, M., and Cuttitta, F. (2000) Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14, 848-862.
36. Gerber, H.P., Condorelli, F., Park, J., and Ferrara, N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659-23667.
37. Gerosa, M.A., Talarico, D., Fognani, C., Raimondi, E., Colombatti, M., Tridente, G., De Carli, L., and Della Valle, G. (1989) Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J. Natl. Cancer Inst. 81, 63-67.
38. Gothie, E., Richard, D.E., Berra, E., Pages, G., and Pouyssegur, J. (2000) Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha. J. Biol. Chem. 275, 6922-6927.
39. Grant, M.B., Caballero, S., Bush, D.M., and Spoerri, P.E. (1998) Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes 47, 1335-1340.
40. Gunaratnam, L., Morley, M., Franovic, A., de Paulsen, N., Mekhail, K., Parolin, D.A., Nakamura, E., Lorimer, I.A., and Lee, S. (2003) Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J. Biol. Chem. 278, 44966-44974.
41. Hara, S., Hamada, J., Kobayashi, C., Kondo, Y., and Imura, N. (2001) Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: Suppression of HIF-mediated gene expression by HIF-3alpha. Biochem. Biophys. Res. Commun. 287, 808-813.
42. Hjelmeland, M.D., Hjelmeland, A.B., Sathornsumetee, S., Reese, E.D., Herbstreith, M.H., Laping, N.J., Friedman, H.S., Bigner, D.D., Wang, X.F., and Rich, J.N. (2004) SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol. Cancer Ther. 3, 737-745.
43. Hjortland, G.O., Lillehammer, T., Somme, S., Wang, J., Halvorsen, T., Juell, S., Hirschberg, H., Fodstad, O., and Engebraaten, O. (2004) Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells. Exp. Cell Res. 294, 130-139.
44. Holash, J., Maisonpierre, P.C., Compton, D., Boland, P., Alexander, C.R., Zagzag, D., Yancopoulos, G.D., and Wiegand, S.J. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998.
45. Holland, E.C., Hively, W.P., DePinho, R.A., and Varmus, H.E. (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675-3685.
46. Hu, J., Discher, D.J., Bishopric, N.H., and Webster, K.A. (1998) Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245, 894-899.
47. Hu, P., Margolis, B., Skolnik, E.Y., Lammers, R., Ullrich, A., and Schlessinger, J. (1992) Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell Biol. 12, 981-990.
48. Hunter, S.B., Brat, D.J., Olson, J.J., Von Deimling, A., Zhou, W., and Van Meir, E.G. (2003) Alterations in molecular pathways of diffusely infiltrating glial neoplasms: Application to tumor classification and antitumor therapy. Int. J. Oncol. 23, 857-869.
49. Hur, E., Chang, K.Y., Lee, E., Lee, S.K., and Park, H. (2001) Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the transactivation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol. 59, 1216-1224.
50. Iimuro, S., Shindo, T., Moriyama, N., Amaki, T., Niu, P., Takeda, N., Iwata, H., Zhang, Y., Ebihara, A., and Nagai, R. (2004) Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ. Res. 95, 415-423.
51. Isogai, C., Laug, W.E., Shimada, H., Declerck, P.J., Stins, M.F., Durden, D.L., Erdreich-Epstein, A., and DeClerck, Y.A. (2001) Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 61, 5587-5594.
52. Iwasaki, H., Hirata, Y., Iwashina, M., Sato, K., and Marumo, F. (1996) Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology 137, 3045-3050.
53. Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., and Kuck, K.H. (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res. 64, 326-333.
54. Jelkmann, W., and Wagner, K. (2004) Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann. Hematol. 83, 673-686.
55. Jeong, J.W., Bae, M.K., Ahn, M.Y., Kim, S.H., Sohn, T.K., Bae, M.H., Yoo, M.A., Song, E.J., Lee, K.J., and Kim, K.W. (2002) Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111, 709-720.
56. Jougasaki, M., and Burnett, J.C., Jr. (2000) Adrenomedullin: Potential in physiology and pathophysiology. Life Sci. 66, 855-872.
57. Jung, F., Palmer, L.A., Zhou, N., and Johns, R.A. (2000) Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86, 319-325.
58. Kaelin, W.G., Jr. (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2, 673-682.
59. Kaur, B., Tan, C., Brat, D.J., Post, D.E., and Van Meir, E.G. (2004) Genetic and hypoxic regulation of angiogenesis in glioma. J. Neurooncol. 70, 229-243.
60. Kelly, B.D., Hackett, S.F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P.A., and Semenza, G.L. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93, 1074-1081.
61. Kietzmann, T., Samoylenko, A., Roth, U., and Jungermann, K. (2003) Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 101, 907-914.
62. Kim, I., Kim, J.H., Ryu, Y.S., Jung, S.H., Nah, J.J., and Koh, G.Y. (2000) Characterization and expression of a novel alternatively spliced human angiopoietin-2. J. Biol. Chem. 275, 18550-18556.
63. Kim, W., Moon, S.O., Sung, M.J., Kim, S.H., Lee, S., So, J.N., and Park, S.K. (2003) Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J. 17, 1937-1939.
64. Kitamuro, T., Takahashi, K., Nakayama, M., Murakami, O., Hida, W., Shirato, K., and Shibahara, S. (2000) Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. J. Neurochem. 75, 1826-1833.
65. Kline, D.D., Peng, Y.J., Manalo, D.J., Semenza, G.L., and Prabhakar, N.R. (2002) Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha. Proc. Natl. Acad. Sci. USA 99, 821-826.
66. Krieg, M., Marti, H.H., and Plate, K.H. (1998) Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 92, 3388-3393.
67. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., and Semenza, G.L. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143.
68. Kroncke, K.D., Fehsel, K., and Kolb-Bachofen, V. (1997) Nitric oxide: Cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1, 107-120.
69. Kung, A.L., Zabludoff, S.D., France, D.S., Freedman, S.J., Tanner, E.A., Vieira, A., Cornell-Kennon, S., Lee, J., Wang, B., Wang, J., Memmert, K., Naegeli, H.U., Petersen, F., Eck, M.J., Bair, K.W., Wood, A.W., and Livingston, D.M. (2004) Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6, 33-43.
70. Kurimoto, M., Endo, S., Arai, K., Horie, Y., Nogami, K., and Takaku, A. (1994) TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion. J. Neurooncol. 22, 33-44.
71. Lakka, S.S., Gondi, C.S., Yanamandra, N., Olivero, W.C., Dinh, D.H., Gujrati, M., and Rao, J.S. (2004) Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23, 4681-4689.
72. Lando, D., Pongratz, I., Poellinger, L., and Whitelaw, M.L. (2000) A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J. Biol. Chem. 275, 4618-4627.
73. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., and Bruick, R.K. (2002a) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
74. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. (2002b) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
75. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C., and Semenza, G.L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 21, 3995-4004.
76. Lee, K.H., Park, J.W., and Chun, Y.S. (2004) Non-hypoxic transcriptional activation of the aryl hydrocarbon receptor nuclear translocator in concert with a novel hypoxia-inducible factor-1alpha isoform. Nucleic Acids Res. 32, 5499-5511.
77. Leitlein, J., Aulwurm, S., Waltereit, R., Naumann, U., Wagenknecht, B., Garten, W., Weller, M., and Platten, M. (2001) Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J. Immunol. 166, 7238-7243.
78. Leungwattanakij, S., Bivalacqua, T.J., Usta, M.F., Yang, D.Y., Hyun, J.S., Champion, H.C., Abdel-Mageed, A.B., and Hellstrom, W.J. (2003) Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J. Androl. 24, 239-245.
79. Li, J.M., Wu, X.L., Zhu, Q.J., and Wang, Q.J. (2002a) [Endothelin-1 expression and quantitative analysis in astrocytomas]. [Chinese] Ai Zheng 21, 1109-1111.
80. Li, Z., Shimada, Y., Uchida, S., Maeda, M., Kawabe, A., Mori, A., Itami, A., Kano, M., Watanabe, G., and Imamura, M. (2000b) TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int. J. Oncol. 17, 453-460.
81. Lolmede, K., Durand de Saint Front, V., Galitzky, J., Lafontan, M., and Bouloumie, A. (2003) Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int. J. Obes. Relat. Metab. Disord. 27, 1187-1195.
82. Machein, M.R., Knedla, A., Knoth, R., Wagner, S., Neuschl, E., and Plate, K.H. (2004) Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am. J. Pathol. 165, 1557-1570.
83. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., and Poellinger, L. (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
84. Martinez, A., Zudaire, E., Portal-Nunez, S., Guedez, L., Libutti, S.K., Stetler-Stevenson, W.G., and Cuttitta, F. (2004) Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res. 64, 6489-6494.
85. Massague, J., and Wotton, D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19, 1745-1754.
86. Mateo, J., Garcia-Lecea, M., Cadenas, S., Hernandez, C., and Moncada, S. (2003) Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J. 376, 537-544.
87. Maynard, M.A., and Ohh, M. (2004) Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am. J. Nephrol. 24, 1-13.
88. Maynard, M.A., Qi, H., Chung, J., Lee, E.H., Kondo, Y., Hara, S., Conaway, R.C., Conaway, J.W., and Ohh, M. (2003) Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040.
89. McMahon, G.A., Dignam, J.D., and Gentry, L.E. (1996) Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. Biochem J. 313 (Pt. 1), 343-351.
90. Mentlein, R., Forstreuter, F., Mehdorn, H.M., and Held-Feindt, J. (2004) Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. J. Neurooncol. 67, 9-18.
91. Metzen, E., Stiehl, D.P., Doege, K., Marxsen, J.H., Hellwig-Burgel, T., and Jelkmann, W. (2004) Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: Identification of a functional hypoxia-responsive element. Biochem. J., published online November 24 (http://www.biochemj.org).
92. Miao, H.Q., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. (2000) Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14, 2532-2539.
93. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
94. Mori, T., Abe, T., Wakabayashi, Y., Hikawa, T., Matsuo, K., Yamada, Y., Kuwano, M., and Hori, S. (2000) Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor. J. Neurooncol. 46, 115-123.
95. Mottonen, J., Strand, A., Symersky, J., Sweet, R.M., Danley, D.E., Geoghegan, K.F., Gerard, R.D., and Goldsmith, E.J. (1992) Structural basis of latency in plasminogen activator inhibitor-1. Nature 355, 270-273.
96. Muracciole, X., Romain, S., Dufour, H., Palmari, J., Chinot, O., Ouafik, L., Grisoli, F., Branger, D.F., and Martin, P.M. (2002) PAI-1 and EGFR expression in adult glioma tumors: Toward a molecular prognostic classification. Int. J. Radiat. Oncol. Biol. Phys. 52, 592-598.
97. Murga, M., Fernandez- Capetillo, O., and Tosato, G. (2004) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood, published online November 2 (http://www.bloodjournal.org).
98. Nakayama, K., Frew, I.J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P.B., Bowtell, D.D., and Ronai, Z. (2004) Siah2 regulates stability of prolylhydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952.
99. Newton, H.B. (2004) Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Expert Rev. Anticancer Ther. 4, 105-128.
100. Nilsson, I., Shibuya, M., and Wennstrom, S. (2004) Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp. Cell Res. 299, 476-485.
101. Nister, M., Libermann, T.A., Betsholtz, C., Pettersson, M., Claesson-Welsh, L., Heldin, C.H., Schlessinger, J., and Westermark, B. (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res. 48, 3910-3918.
102. Norman, J.T., Clark, I.M., and Garcia, P.L. (2000) Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 58, 2351-2366.
103. Obara, S., Nakata, M., Takeshima, H., Katagiri, H., Asano, T., Oka, Y., Maruyama, I., and Kuratsu, J. (2004) Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Cancer Lett. 208, 115-122.
104. Oehler, M.K., Hague, S., Rees, M.C., and Bicknell, R. (2002) Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 21, 2815-2821.
105. Onesto, C., Berra, E., Grepin, R., and Pages, G. (2004) Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA. J. Biol. Chem. 279, 34217-34226.
106. Osada, H., Tokunaga, T., Nishi, M., Hatanaka, H., Abe, Y., Tsugu, A., Kijima, H., Yamazaki, H., Ueyama, Y., and Nakamura, M. (2004) Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res. 24, 547-552.
107. Osenkowski, P., Toth, M., and Fridman, R. (2004) Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell Physiol. 200, 2-10.
108. Ouafik, L., Sauze, S., Boudouresque, F., Chinot, O., Delfino, C., Fina, F., Vuaroqueaux, V., Dussert, C., Palmari, J., Dufour, H., Grisoli, F., Casellas, P., Brunner, N., and Martin, P. M. (2002) Neutralization of adreno-medullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am. J. Pathol. 160, 1279-1292.
109. Palmer, L.A., Semenza, G.L., Stoler, M.H., and Johns, R.A. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274, L212-219.
110. Paul, S.A., Simons, J.W., and Mabjeesh, N.J. (2004) HIF at the crossroads between ischemia and carcinogenesis. J. Cell Physiol. 200, 20-30.
111. Ploplis, V.A., Balsara, R., Sandoval-Cooper, M.J., Yin, Z.J., Batten, J., Modi, N., Gadoua, D., Donahue, D., Martin, J.A., and Castellino, F.J. (2004) Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice. J. Biol. Chem. 279, 6143-6151.
112. Post, D.E., Devi, N.S., Li, Z., Brat, D.J., Kaur, B., Nicholson, A., Olson, J.J., Zhang, Z., and Van Meir, E.G. (2004) Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clin Cancer Res. 10, 8603-8612.
113. Rakic, J.M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.M., and Noel, A. (2003) Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol. Life Sci. 60, 463-473.
114. Ravi, R., Mookerjee, B., Bhujwalla, Z.M., Sutter, C.H., Artemov, D., Zeng, Q., Dillehay, L.E., Madan, A., Semenza, G.L., and Bedi, A. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14, 34-44.
115. Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell'Era, P., Nico, B., Roncali, L., and Dammacco, F. (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93, 2627-2636.
116. Ribatti, D., Guidolin, D., Conconi, M.T., Nico, B., Baiguera, S., Parnigotto, P.P., Vacca, A., and Nussdorfer, G.G. (2003) Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 22, 6458-6461.
117. Rich, J.N., Zhang, M., Datto, M.B., Bigner, D.D., and Wang, X.F. (1999) Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274, 35053-35058.
118. Rong, Y., Post, D.E., Pieper, R.O., Durden, D.L., Van Meir, E.G., and Brat, D.J. (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res., 65, 1406-1413.
119. Rubenstein, M., Glick, R., Lichtor, T., Mirochnik, Y., Chou, P., and Guinan, P. (2001) Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. Med. Oncol. 18, 121-130.
120. Salani, D., Taraboletti, G., Rosano, L., Di Castro, V., Borsotti, P., Giavazzi, R., and Bagnato, A. (2000) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol. 157, 1703-1711.
121. Salvati, M., Cervoni, L., Artico, M., Caruso, R., and Gagliardi, F.M. (1998) Long-term survival in patients with supratentorial glioblastoma. J. Neurooncol. 36, 61-64.
122. Sanchez-Elsner, T., Botella, L.M., Velasco, B., Corbi, A., Attisano, L., and Bernabeu, C. (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276, 38527-38535.
123. Sansal, I., and Sellers, W. R. (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J. Clin. Oncol. 22, 2954-2963.
124. Schaffer, L., Scheid, A., Spielmann, P., Breymann, C., Zimmermann, R., Meuli, M., Gassmann, M., Marti, H.H., and Wenger, R.H. (2003) Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta 24, 941-950.
125. Scheld, A., Wenger, R.H., Christina, H., Camenisch, I., Ferenc, A., Stauffer, U.G., Gassmann, M., and Meuli, M. (2000) Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair. Pediatr. Surg. Int. 16, 232-236.
126. Schenk, S., Hintermann, E., Bilban, M., Koshikawa, N., Hojilla, C., Khokha, R., and Quaranta, V. (2003) Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161, 197-209.
127. Schlegel, U., Moots, P.L., Rosenblum, M.K., Thaler, H.T., and Furneaux, H.M. (1990) Expression of transforming growth factor alpha in human gliomas. Oncogene 5, 1839-1842.
128. Schreiber, A.B., Winkler, M.E., and Derynck, R. (1986) Transforming growth factor-alpha: A more potent angiogenic mediator than epidermal growth factor. Science 232, 1250-1253.
129. Schuster, S.J., Koury, S.T., Bohrer, M., Salceda, S., and Caro, J. (1992) Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br. J. Haematol. 81, 153-159.
130. Seeler, J.S., and Dejean, A. (2003) Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4, 690-699.
131. Semenza, G. (2002) Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64, 993-998.
132. 2-regulated gene expression: Transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96, 1173-1177.
133. Semenza, G.L., and Wang, G.L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12, 5447-5454.
134. Semenza, G.L., Nejfelt, M.K., Chi, S.M., and Antonarakis, S.E. (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 88, 5680-5684.
135. Senger, D., Cairncross, J.G., and Forsyth, P.A. (2003) Long-term survivors of glioblastoma: Statistical aberration or important unrecognized molecular subtype? Cancer J. 9, 214-221.
136. Shao, R., Zhang, F.P., Tian, F., Anders Friberg, P., Wang, X., Sjoland, H., and Billig, H. (2004) Increase of SUMO-1 expression in response to hypoxia: Direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Lett. 569, 293-300.
137. Shindo, T., Kurihara, Y., Nishimatsu, H., Moriyama, N., Kakoki, M., Wang, Y., Imai, Y., Ebihara, A., Kuwaki, T., Ju, K.H., Minamino, N., Kangawa, K., Ishikawa, T., Fukuda, M., Akimoto, Y., Kawakami, H., Imai, T., Morita, H., Yazaki, Y., Nagai, R., Hirata, Y., and Kurihara, H. (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104, 1964-1971.
138. Siren, A.L., Knerlich, F., Poser, W., Gleiter, C.H., Bruck, W., and Ehrenreich, H. (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 101, 271-276.
139. Sone, M., Takahashi, K., Totsune, K., Murakami, O., Arihara, Z., Satoh, F., Mouri, T., and Shibahara, S. (2000) Expression of endothelin-1 and endothelin receptors in cultured human glioblastoma cells. J. Cardiovasc. Pharmacol. 36, S390-392.
140. Spinella, F., Rosano, L., Di Castro, V., Natali, P. G., and Bagnato, A. (2002) Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J. Biol. Chem. 277, 27850-27855.
141. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T. N., and Yancopoulos, G.D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
142. Tait, C.R., and Jones, P.F. (2004) Angiopoietins in tumours: The angiogenic switch. J. Pathol. 204, 1-10.
143. Takahashi, K., Totsune, K., Kitamuro, T., Sone, M., Murakami, O., and Shibahara, S. (2002) Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: Expression and effects on proliferation. Clin. Sci. (Lond.) 103 (suppl. 48), 35S-38S.
144. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S., and Nose, T. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56, 2185-2190.
145. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, Ji J., Hirota, S., Kitamura, Y., Kitsukawa, T., Fujisawa, H., Klagsbrun, M., and Hori, M. (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 99, 3657-3662.
146. Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli, L., Costello, P., Sutton, K., Wheeler, J., Gleave, M., Sanghera, J., and Dedhar, S. (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5, 79-90.
147. Tan, C., de Noronha, R.G., Roecker, A.J., Pyrzynska, B., Khwaja, F., Zhang, Z., Zhang, H., Teng, Q., Nicholson, A.C., Giannakakou, P., Zhou, W., Olson, J.J., Pereira, M.M., Nicolaou, K.C., and Van Meir, E.G. (2005) Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res. 65, 605-612.
148. Tang, P., Jasser, S.A., Sung, J.C., Shi, Y., Steck, P.A., and Yung, W.K. (1999) Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth. J. Neurooncol. 43, 127-135.
149. Thorns, V., Walter, G.F., and Thorns, C. (2003) Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res. 23, 3937-3944.
150. Tian, H., McKnight, S.L., and Russell, D.W. (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72-82.
151. Tian, H., Hammer, R.E., Matsumoto, A.M., Russell, D.W., and McKnight, S.L. (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12, 3320-3324.
152. Tuckerman, J.R., Zhao, Y., Hewitson, K.S., Tian, Y.M., Pugh, C.W., Ratcliffe, P.J., and Mole, D.R. (2004) Determination and comparison of specific activity of the HIF-prolyl hydroxylases. FEBS Lett. 576, 145-150.
153. Valenzuela, D.M., Griffiths, J.A., Rojas, J., Aldrich, T.H., Jones, P.F., Zhou, H., McClain, J., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Huang, T., Papadopoulos, N., Maisonpierre, P.C., Davis, S., and Yancopoulos, G.D. (1999) Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96, 1904-1909.
154. Van Meir, E.G. (1995) Cytokines and tumors of the central nervous system. Glia. 15, 264-288.
155. Van Meter, T.E., Broaddus, W.C., Rooprai, H.K., Pilkington, G.J., and Fillmore, H.L. (2004) Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. Neuro-Oncol. 6, 188-199.
156. Waha, A., Baumann, A., Wolf, H.K., Fimmers, R., Neumann, J., Kindermann, D., Astrahantseff, K., Blumcke, I., von Deimling, A., and Schlegel, U. (1996) Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. J. Neurosurg. 85, 634-641.
157. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
158. Wang, Y., Kilic, E., Kilic, U., Weber, B., Bassetti, C.L., Marti, H.H., and Hermann, D.M. (2004a) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain, published online October 27 (http://brain.oupjournals.org).
159. Wang, F.S., Wang, C.J., Chen, Y.J., Chang, P.R., Huang, Y.T., Sun, Y.C., Huang, H.C., Yang, Y.J., and Yang, K.D. (2004b) Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J. Biol. Chem. 279, 10331-10337.
160. Westenfelder, C., and Baranowski, R.L. (2000) Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 58, 647-657.
161. Wick, W., Platten, M., and Weller, M. (2001) Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta. J. Neurooncol. 53, 177-185.
162. Wieser, R. (2001) The transforming growth factor-beta signaling pathway in tumorigenesis. Curr. Opin. Oncol. 13, 70-77.
163. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T., and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
164. Xu, Y., Liu, Y.J., and Yu, Q. (2004) Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis. Cancer Res. 64, 6119-6126.
165. Yamada, N., Kato, M., Yamashita, H., Nister, M., Miyazono, K., Heldin, C.H., and Funa, K. (1995) Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int. J. Cancer 62, 386-392.
166. Yamaguchi, S., Bell, H.S., Shinoda, J., Holmes, M.C., Wharton, S.B., and Whittle, I.R. (2002) Glioma tumourgenicity is decreased by iNOS knockout: Experimental studies using the C6 striatal implantation glioma model. Br. J. Neurosurg. 16, 567-572.
167. Yamakawa, M., Liu, L.X., Date, T., Belanger, A.J., Vincent, K.A., Akita, G.Y., Kuriyama, T., Cheng, S.H., Gregory, R.J., and Jiang, C. (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ. Res. 93, 664-673.
168. Yin, J.H., Yang, D.I., Ku, G., and Hsu, C.Y. (2000) iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem. Biophys. Res. Commun. 279, 30-34.
169. Yoshida, D., Takahashi, H., and Teramoto, A. (2004) Inhibition of glioma angiogenesis and invasion by SI-27, an anti-matrix metalloproteinase agent in a rat brain tumor model. Neurosurgery 54, 1213-1220.
170. Yung, W.K., Zhang, X., Steck, P.A., and Hung, M.C. (1990) Differential amplification of the TGF-alpha gene in human gliomas. Cancer Commun. 2, 201-205.
171. Zadeh, G., and Guha, A. (2003) Neoangiogenesis in human astrocytomas: Expression and functional role of angiopoietins and their cognate receptors. Front Biosci. 8, e128-e137.
172. Zadeh, G., Koushan, K., Pillo, L., Shannon, P., and Guha, A. (2004a) Role of Ang1 and its interaction with VEGF-A in astrocytomas. J. Neuropathol. Exp. Neurol. 63, 978-989.
173. Zadeh, G., Qian, B., Okhowat, A., Sabha, N., Kontos, C.D., and Guha, A. (2004b) Targeting the tie2/tek receptor in astrocytomas. Am. J. Pathol. 164, 467-476.
174. Zagzag, D., Hooper, A., Friedlander, D.R., Chan, W., Holash, J., Wiegand, S.J., Yancopoulos, G.D., and Grumet, M. (1999) In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp. Neurol. 159, 391-400.
175. Zagzag, D., Zhong, H., Scalzitti, J.M., Laughner, E., Simons, J.W., and Semenza, G.L. (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 88, 2606-2618.
176. Zhang, H., Akman, H.O., Smith, E.L., Zhao, J., Murphy-Ullrich, J.E., and Batuman, O.A. (2003) Cellular response to hypoxia involves signaling via Smad proteins. Blood 101, 2253-2260.
177. Zhang, Q., Wu, Y., Chau, C.H., Ann, D.K., Bertolami, C.N., and Le, A.D. (2004) Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J. Cell Physiol. 199, 89-97.
178. Zhao, Y., Hague, S., Manek, S., Zhang, L., Bicknell, R., and Rees, M.C. (1998) PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 16, 409-415.
179. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Simons, J.W., and Semenza, G.L. (2000) Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.
180. Zhou, J., Schmid, T., Frank, R., and Brune, B. (2004) PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J. Biol. Chem. 279, 13506-13513.
181. Ziegler, S.F., Bird, T.A., Schneringer, J.A., Schooley, K.A., and Baum, P.R. (1993) Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8, 663-670.
182. Ziel, K.A., Campbell, C.C., Wilson, G.L., and Gillespie, M.N. (2004) Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J. 18, 986-988.
183. Zimmermann, U., Fischer, J.A., Frei, K., Fischer, A.H., Reinscheid, R.K., and Muff, R. (1996) Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastoma x glioma hybrid cells (NG108-15). Brain Res. 724, 238-245.
184. Zudaire, E., Martinez, A., and Cuttitta, F. (2003) Adrenomedullin and cancer. Regul. Pept. 112, 175-183.
185. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B., Stokoe, D., and Giaccia, A.J. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391-396.